885
Participants
Start Date
January 31, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
Azilsartan medoxomil
Azilsartan medoxomil 20 mg, tablets, orally, once daily for two weeks; then increased to 40 mg, tablets, orally, once daily for up to 22 weeks.
Azilsartan medoxomil
Azilsartan medoxomil 20 mg, tablets, orally, once daily for two weeks; then increased to 80 mg, tablets, orally, once daily for up to 22 weeks.
Ramipril
Ramipril 2.5 mg, tablets, orally, once daily for two weeks; then increased to 10 mg, tablets, orally, once daily for up to 22 weeks.
Pleven
Plovdiv
Rousse
Sofia
Varna
Paide
Tallinn
Tartu
Viljandi
Joensuu
Mikkeli
Tampere
Turku
Augsburg
Bad Krozingen
Bad Segeberg
Berlin
Cologne
Dortmund
Dresden
Essen
Frankfurt
Goch
Großheirath
Hamburg
Karlsruhe
Künzing
Leipzig
Lübeck
Mannheim
München
Nuremberg
Siegen
Deurne
Ewijk
Geleen
Lichtenvoorde
Oude Pekela
Rijswijk
Roelofarendsveen
Rotterdam
Wildervank
Gdansk
Gniewkowo
Kamieniec Ząbkowicki
Katowice
Libiąż
Lodz
Oława
Poznan
Płock
Skierniewice
Tarnów
Moscow
Perm
Saint Petersburg
Belgrade
Niš
Niška Banja
Zemun
Bratislava
Galanta
Levice
Lučenec
Rimavská Sobota
Boden
Gothenburg
Luleå
Lund
Malmo
Örebro
Skene
Lead Sponsor
Takeda
INDUSTRY